Da leveren antages at være den primære eliminationsvej for Aranesp og r- HuEPO, bør Aranesp altid anvendes med forsigtighed af patienter med leversygdom.
Since the liver is thought to be the principal route of elimination of Aranesp and r-HuEPO, Aranesp should be used with caution in patients with liver disease.